ASX - By Stock
|
SPL |
Re:
Biotech Daily editorial FYI
|
|
jazzapat
|
18 |
4.7K |
3 |
21/04/20 |
21/04/20 |
ASX - By Stock
|
18
|
4.7K
|
3
|
|
ASX - By Stock
|
NHC |
Re:
Ann: New Hope welcomes Court of Appeal decision
|
|
jazzapat
|
43 |
68K |
2 |
16/04/20 |
16/04/20 |
ASX - By Stock
|
43
|
68K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Remdesivir (Gilead) is currently a leading candidate for the treatment of COVID-19.
|
|
jazzapat
|
40 |
13K |
2 |
16/04/20 |
16/04/20 |
ASX - By Stock
|
40
|
13K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
wow wow wow wow wow wow wow wow wow
|
|
jazzapat
|
60 |
20K |
3 |
16/04/20 |
16/04/20 |
ASX - By Stock
|
60
|
20K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Cashflow and Activity Report
|
|
jazzapat
|
80 |
22K |
0 |
08/04/20 |
08/04/20 |
ASX - By Stock
|
80
|
22K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Cashflow and Activity Report
|
|
jazzapat
|
80 |
22K |
1 |
08/04/20 |
08/04/20 |
ASX - By Stock
|
80
|
22K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Cashflow and Activity Report
|
|
jazzapat
|
80 |
22K |
1 |
07/04/20 |
07/04/20 |
ASX - By Stock
|
80
|
22K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Cashflow and Activity Report
|
|
jazzapat
|
80 |
22K |
3 |
07/04/20 |
07/04/20 |
ASX - By Stock
|
80
|
22K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Conjunctivitis medical press
|
|
jazzapat
|
23 |
6.6K |
11 |
29/03/20 |
29/03/20 |
ASX - By Stock
|
23
|
6.6K
|
11
|
|
ASX - By Stock
|
SPL |
Re:
Starpharma: Beaten Up By COVID-19 For No Reason
|
|
jazzapat
|
14 |
4.7K |
2 |
29/03/20 |
29/03/20 |
ASX - By Stock
|
14
|
4.7K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Thoughts
|
|
jazzapat
|
15 |
3.8K |
1 |
24/03/20 |
24/03/20 |
ASX - By Stock
|
15
|
3.8K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Okamoto licenses VivaGel antiviral condom in Asian countries
|
|
jazzapat
|
21 |
8.3K |
2 |
05/03/20 |
05/03/20 |
ASX - By Stock
|
21
|
8.3K
|
2
|
|
ASX - By Stock
|
LNK |
Re:
Where to now for Link
|
|
jazzapat
|
517 |
1.1M |
11 |
29/02/20 |
29/02/20 |
ASX - By Stock
|
517
|
1.1M
|
11
|
|
ASX - By Stock
|
SPL |
Re:
DEP Docetaxel: Imagine effective chemo without side effects!
|
|
jazzapat
|
11 |
253K |
3 |
29/02/20 |
29/02/20 |
ASX - By Stock
|
11
|
253K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Something in the air??
|
|
jazzapat
|
27 |
19K |
0 |
20/02/20 |
20/02/20 |
ASX - By Stock
|
27
|
19K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VivaGel BV launched in Asia
|
|
jazzapat
|
37 |
14K |
2 |
13/02/20 |
13/02/20 |
ASX - By Stock
|
37
|
14K
|
2
|
|
ASX - By Stock
|
TAH |
Re:
Tabcorp Dividends
|
|
jazzapat
|
9 |
7.0K |
1 |
07/02/20 |
07/02/20 |
ASX - By Stock
|
9
|
7.0K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Shareholder Update January 2020
|
|
jazzapat
|
15 |
6.6K |
7 |
30/01/20 |
30/01/20 |
ASX - By Stock
|
15
|
6.6K
|
7
|
|
ASX - By Stock
|
NHC |
Re:
Just another day in the shitter
|
|
jazzapat
|
25 |
22K |
5 |
28/01/20 |
28/01/20 |
ASX - By Stock
|
25
|
22K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
2020 is our year
|
|
jazzapat
|
218 |
575K |
2 |
23/01/20 |
23/01/20 |
ASX - By Stock
|
218
|
575K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
2020 is our year
|
|
jazzapat
|
218 |
575K |
6 |
23/01/20 |
23/01/20 |
ASX - By Stock
|
218
|
575K
|
6
|
|
ASX - By Stock
|
RUL |
Re:
Managed fund- Info
|
|
jazzapat
|
4 |
2.4K |
1 |
14/01/20 |
14/01/20 |
ASX - By Stock
|
4
|
2.4K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Who's topping up
|
|
jazzapat
|
103 |
34K |
2 |
12/12/19 |
12/12/19 |
ASX - By Stock
|
103
|
34K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: DEP cabazitaxel progresses to phase 2 on positive results
|
|
jazzapat
|
21 |
9.4K |
1 |
10/12/19 |
10/12/19 |
ASX - By Stock
|
21
|
9.4K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
What's the long term plan for the lVivaGel® portfolio
|
|
jazzapat
|
11 |
4.5K |
1 |
25/11/19 |
25/11/19 |
ASX - By Stock
|
11
|
4.5K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
What's the long term plan for the lVivaGel® portfolio
|
|
jazzapat
|
11 |
4.5K |
1 |
25/11/19 |
25/11/19 |
ASX - By Stock
|
11
|
4.5K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: AGM - Chairman address and CEO presentation
|
|
jazzapat
|
55 |
21K |
12 |
23/11/19 |
23/11/19 |
ASX - By Stock
|
55
|
21K
|
12
|
|
ASX - By Stock
|
SPL |
Re:
Ann: 2019 AGM details
|
|
jazzapat
|
16 |
6.9K |
2 |
21/11/19 |
21/11/19 |
ASX - By Stock
|
16
|
6.9K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: DEP outperforms Gemzar in human pancreatic cancer model
|
|
jazzapat
|
38 |
13K |
8 |
31/10/19 |
31/10/19 |
ASX - By Stock
|
38
|
13K
|
8
|
|
ASX - By Stock
|
SPL |
Re:
Assessing the Vivagel income
|
|
jazzapat
|
6 |
2.3K |
2 |
29/10/19 |
29/10/19 |
ASX - By Stock
|
6
|
2.3K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Zita Peach & voting
|
|
jazzapat
|
3 |
1.9K |
13 |
19/10/19 |
19/10/19 |
ASX - By Stock
|
3
|
1.9K
|
13
|
|
ASX - By Stock
|
SPL |
Re:
Ann: FDA Authorises Clinical Trial with AstraZeneca DEP product
|
|
jazzapat
|
26 |
11K |
6 |
26/09/19 |
26/09/19 |
ASX - By Stock
|
26
|
11K
|
6
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Promising efficacy signals observed in ongoing DEP trials
|
|
jazzapat
|
23 |
9.2K |
5 |
28/08/19 |
28/08/19 |
ASX - By Stock
|
23
|
9.2K
|
5
|
|
ASX - By Stock
|
RUL |
Re:
Ann: Annual Recurring Revenue (ARR) Software Subscriptions
|
|
jazzapat
|
1 |
637 |
3 |
23/08/19 |
23/08/19 |
ASX - By Stock
|
1
|
637
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: First Asian Regulatory Approvals Received for VivaGel BV
|
|
jazzapat
|
15 |
10K |
4 |
15/08/19 |
15/08/19 |
ASX - By Stock
|
15
|
10K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Annual Report due in ~2 weeks
|
|
jazzapat
|
11 |
5.0K |
1 |
05/08/19 |
05/08/19 |
ASX - By Stock
|
11
|
5.0K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Predictions
|
|
jazzapat
|
34 |
10K |
3 |
01/08/19 |
01/08/19 |
ASX - By Stock
|
34
|
10K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Cashflow Report
|
|
jazzapat
|
14 |
7.3K |
5 |
16/07/19 |
16/07/19 |
ASX - By Stock
|
14
|
7.3K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
cash in bank
|
|
jazzapat
|
3 |
1.5K |
3 |
05/07/19 |
05/07/19 |
ASX - By Stock
|
3
|
1.5K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: US patent granted for DEP Bcl2/xL inhibitor conjugates
|
|
jazzapat
|
17 |
9.1K |
2 |
12/06/19 |
12/06/19 |
ASX - By Stock
|
17
|
9.1K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Okamoto launches VivaGel condom in Japan
|
|
jazzapat
|
23 |
13K |
1 |
04/06/19 |
04/06/19 |
ASX - By Stock
|
23
|
13K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Inking of deals at ASCO 2019
|
|
jazzapat
|
29 |
11K |
11 |
03/06/19 |
03/06/19 |
ASX - By Stock
|
29
|
11K
|
11
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma presents at UBS Healthcare Conference
|
|
jazzapat
|
12 |
5.4K |
11 |
29/05/19 |
29/05/19 |
ASX - By Stock
|
12
|
5.4K
|
11
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Regulatory progress for VivaGel BV in the US
|
|
jazzapat
|
60 |
18K |
6 |
23/05/19 |
23/05/19 |
ASX - By Stock
|
60
|
18K
|
6
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Regulatory progress for VivaGel BV in the US
|
|
jazzapat
|
60 |
18K |
0 |
23/05/19 |
23/05/19 |
ASX - By Stock
|
60
|
18K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Regulatory progress for VivaGel BV in the US
|
|
jazzapat
|
60 |
18K |
6 |
23/05/19 |
23/05/19 |
ASX - By Stock
|
60
|
18K
|
6
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Regulatory progress for VivaGel BV in the US
|
|
jazzapat
|
60 |
18K |
3 |
23/05/19 |
23/05/19 |
ASX - By Stock
|
60
|
18K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Regulatory progress for VivaGel BV in the US
|
|
jazzapat
|
60 |
18K |
12 |
23/05/19 |
23/05/19 |
ASX - By Stock
|
60
|
18K
|
12
|
|
ASX - By Stock
|
SPL |
Re:
Meaning of 2 indications in Starpharma VivaGel announcement of 20-12-2018
|
|
jazzapat
|
3 |
1.4K |
2 |
22/05/19 |
22/05/19 |
ASX - By Stock
|
3
|
1.4K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma presents at Macquarie Australia Conference
|
|
jazzapat
|
11 |
5.2K |
11 |
02/05/19 |
02/05/19 |
ASX - By Stock
|
11
|
5.2K
|
11
|
|